Focalin XR 30mg approved for attention deficit hyperactivity disorder (ADHD) - MPR

Links shared publicly online about this topic.

  • 1,631
    total visits

Focalin XR 30mg approved for attention deficit hyperactivity disorder (ADHD) - MPR

empr.com

The FDA has approved a higher 30mg dose of Focalin XR (dexmethylphenidate HCl extended-release capsules, from Novartis) for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years of age.

View full resource at empr.com

Tags: ADHD, ADHD Medication, Disease and Condition, FDA, Focalin, Novartis, News

  • Share

Most Recently Shared on November 2, 2009 at 8:33 pm By:

eMPR MPR

MPR News: Focalin XR 30mg approved for attention deficit hyperactivity disorder (ADHD): The FDA has approved a highe... http://bit.ly/2xZtyM

2 years ago...

ADHDLiving's Channel - YouTube

youtube.com — “Attention deficit hyperactivity disorder (ADHD) is a condition in which a person may have problems with attention, hyperactivity, and impulsivity. On this channel, learn about ways you or your child can help manage ADHD with easy, practical advice. Focalin XR® is a stimulant prescription medication approved by the FDA to treat ADHD in patients aged 6 years and older. Ask your doctor if Focalin XR is right for you or your child. Remember, ADHD is a condition that only your health care provider caView full resource at youtube.com

  • View Related
  • Share

Most Recently Shared on November 8, 2011 at 11:54 pm By:

bradatpharma bradatpharma Pharma and Health Social Media

It's nice to see my support can actually result in something launching... snoopy happy dance... #iwork@novartis http://t.co/HokVCfEb

6 months ago...

Advertisement